Solid Biosciences (SLDB) BidaskScore is downgraded to Strongly Sold

Solid Biosciences, Inc.

The BidaskScore of Solid Biosciences Inc. SLDBSLDB shows that the shares of the company are now SLDBStrongly Bought Strongly Sold by investors.

The BidaskScore of the PharmaceuticalsPharmaceuticals shows that the sector is PharmaceuticalsStrongly Bought Strongly Sold since October 1.

Here are the BidAskScore of other related companies in the Pharmaceuticals sector:

Solid Biosciences, Inc. engages in the development of treatments for patients with Duchenne muscular dystrophy. It develops gene therapies, disease modifying therapies, and assistive devices for the cure of DMD. The company was founded by Ilan Ganot, Andrey J. Zarur, Matthew Arnold, Annie Ganot and Gilad David Hayeem in March 2013 and is headquartered in Cambridge, MA.

Solid Biosciences, Inc.

Launched in 2016, the BidAskClubBidaskClub allows users to follow the evolution of the US equity market. BidaskClub provides a platform to create portfolios and be informed when a company´s or sector’s BidaskScore changes. BidaskClub is provided by LuxFinAdviceLuxFinAdvice.